MERCK KGAA NAM.SP.ADR (MRKC) - Total Liabilities

Latest as of September 2025: €21.93 Billion EUR ≈ $25.63 Billion USD

Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has total liabilities worth €21.93 Billion EUR (≈ $25.63 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MRKC cash generation efficiency to assess how effectively this company generates cash.

MERCK KGAA NAM.SP.ADR - Total Liabilities Trend (2020–2024)

This chart illustrates how MERCK KGAA NAM.SP.ADR's total liabilities have evolved over time, based on quarterly financial data. Check MRKC cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

MERCK KGAA NAM.SP.ADR Competitors by Total Liabilities

The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their total liabilities.

Company Country Total Liabilities
China Three Gorges New Energy Group Co Ltd
SHG:600905
China CN¥268.63 Billion
Yum China Holdings Inc
NYSE:YUMC
USA $4.65 Billion
Beijing Kingsoft Office Software In
SHG:688111
China CN¥4.50 Billion
Chocoladefabriken Lindt & Spruengli AG N
SW:LISN
Switzerland CHF3.81 Billion
China Merchants Securities Co Ltd
SHG:600999
China CN¥627.92 Billion
Repsol S.A
F:REPA
Germany €32.71 Billion
Shanghai International Port Group Co Ltd
SHG:600018
China CN¥65.94 Billion
Accelink Technologies Co Ltd
SHE:002281
China CN¥6.54 Billion

Liability Composition Analysis (2020–2024)

This chart breaks down MERCK KGAA NAM.SP.ADR's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MERCK KGAA NAM.SP.ADR (MRKC) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.49 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.76 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MERCK KGAA NAM.SP.ADR's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MERCK KGAA NAM.SP.ADR (2020–2024)

The table below shows the annual total liabilities of MERCK KGAA NAM.SP.ADR from 2020 to 2024.

Year Total Liabilities Change
2024-12-31 €21.58 Billion
≈ $25.23 Billion
-0.74%
2023-12-31 €21.74 Billion
≈ $25.42 Billion
-3.51%
2022-12-31 €22.53 Billion
≈ $26.34 Billion
-5.91%
2021-12-31 €23.95 Billion
≈ $28.00 Billion
-3.36%
2020-12-31 €24.78 Billion
≈ $28.97 Billion
--

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1456 Global
#322 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more